GSK (LSE:GSK) has licensed worldwide rights to its experimental liver disease drug linerixibat to Alfasigma. The agreement ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. GSK (LSE:GSK) has reached a class action settlement in New York related to advertising ...
Hosted on MSN
GSK to acquire US biotech group for $2.2bn
FTSE 100 giant GSK has reached an agreement to acquire US based biotech group Rapt Therapeutics. The deal values the company, which develops therapies for treating people with inflammatory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results